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Abstract
Inflammation is a pathologic feature of hyperuricemia in clinical settings. However, the underlying mechanism remains
unknown. Here, infiltration of T cells and macrophages were significantly increased in hyperuricemia mice kidneys. This
infiltration of inflammatory cells was accompanied by an up-regulation of TNF-a, MCP-1 and RANTES expression. Further,
infiltration was largely located in tubular interstitial spaces, suggesting a role for tubular cells in hyperuricemia-induced
inflammation. In cultured tubular epithelial cells (NRK-52E), uric acid, probably transported via urate transporter, induced
TNF-a, MCP-1 and RANTES mRNA as well as RANTES protein expression. Culture media of NRK-52E cells incubated with uric
acid showed a chemo-attractive ability to recruit macrophage. Moreover uric acid activated NF-kB signaling. The uric acid-
induced up-regulation of RANTES was blocked by SN 50, a specific NF-kB inhibitor. Activation of NF-kB signaling was also
observed in tubule of hyperuricemia mice. These results suggest that uric acid induces renal inflammation via activation of
NF-kB signaling.
Citation: Zhou Y, Fang L, Jiang L, Wen P, Cao H, et al. (2012) Uric Acid Induces Renal Inflammation via Activating Tubular NF-kB Signaling Pathway. PLoS ONE 7(6):
e39738. doi:10.1371/journal.pone.0039738
Editor: Ralf Andreas Linker, Friedrich-Alexander University Erlangen, Germany
Received March 5, 2012; Accepted May 25, 2012; Published June 25, 2012
Copyright:  2012 Zhou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Science Foundation of China Grants 30871201/31171093, ‘‘973’’ Science Program of the Ministry of Science and
Technology, China (2011CB504005), and Jiangsu Province’s Outstanding Medical Academic Leader Program (SWKJ 2006-50) to JY. The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jwyang@njmu.edu.cn
Introduction
A growing number of epidemiologic and experimental evidence
suggests that uric acid is an independent risk fact for cardiovas-
cular and renal disease [1,2,3]. For patients with hypertension,
heart failure or diabetes, hyperuricemia always predicts a high
mortality [4,5,6]. The mechanisms by which uric acid causes
organ injury are still incompletely understood. However, increas-
ing evidence suggests that uric acid is an agent of inflammation
[1,7,8]. It is also well accepted that monosodium urate crystals
stimulated gouty inflammation [9,10]. Moreover, under sterile
conditions, several endogenous substances, especially uric acid
plays an important role in mediating inflammation stimulated by
pathologic insult and tissue damage [11,12]. It is conceivable that
uric acid could elicit inflammation in kidney.
Renal infiltration of T cells and macrophages in interstitial
spaces contributes to the initiation and progression of renal
diseases [13,14]. Inflammatory cells release pro-inflammatory
chemokines and cytokines, which thereby lead to a self-aggrava-
tion of primary insults. In addition, production of pro-fibrotic
cytokines may promote tissue fibrosis by activating matrix-
producing effecter cells, such as tubular cells and fibroblasts.
Our previous investigation showed that uric acid increase matrix
protein fibronectin expression in tubular cells of hyperuricemia
mice [15]. Not surprisingly, hyperuricemia increase the risk of
renal injury via inflammation in clinical settings. NF-kB signaling,
as a key transcription factor, is known to mediate inflammation by
regulating the expression of cytokines and chemokines [14].
Moreover, studies have shown that uric acid could activate NF-kB
signaling in proximal tubular epithelial cells [15,16]. However, the
mechanism by which uric acid induces inflammation in renal
tubule remains unknown.
In this study, we demonstrated that infiltration of T cells and
macrophages were markedly increased in hyperuricemia mice
kidney, accompanied by an up-regulation of TNF-a, MCP-1 and
RANTES expression. Infiltrated cells were largely localized to
tubular interstitial spaces. In tubular epithelial cells (NRK-52E),
uric acid treatment induced TNF-a, MCP-1 and RANTES
mRNA as well as RANTES protein expression. Culture media of
NRK-52E cells incubated with uric acid showed a chemo-
attractive ability to recruit macrophages. Uric acid activates NF-
kB signaling in tubular cell. Moreover the up-regulation of
RANTES was blocked by specific NF-kB inhibitor. Evidence of a
hyperuricemia-induced activation of NF-kB signaling was also
obtained in tubule of hyperuricemia mice. These results suggest
that uric acid induces renal infiltration of inflammatory cells and
tubule expression of inflammatory mediators via activation of NF-
kB signaling.
Results
Uric acid induces inflammatory cells infiltration in renal
tubular interstitial spaces
Figure 1a shows that the continuous intraperitoneally injection
of uric acid induced renal morphological changes, characterized
by dilated tubules, expanded interstitial spaces and increased cell
number. To assess whether uric acid induced inflammatory cells’
infiltration, immunohistochemical staining for CD3 and CD68
were applied. As compared with sham-control group (figure 1b),
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cell infiltration in kidneys at 7d. The renal infiltration of CD3+ T
cell is persistent till 14d. Similarly, figure 1c shows that uric acid
instigated infiltration of CD68 positive macrophages in renal
tubular interstitial spaces. Figure 1d shows the change of serum
uric acid level in hyperuricemia mice after intraperitoneally
injection of uric acid.
Uric acid induces renal expression of inflammatory
cytokines and chemokines
We next examined the expression of RANTES and MCP-1,
pro-inflammatory chemokines inciting infiltration of T cells and
macrophage, in hyperuricemia mice kidneys. As shown in
figure 2a, quantitative PCR (Q-PCR) analysis revealed that
approximately five and four-fold increase of RANTES and
MCP-1 mRNA expressions were observed in mice kidneys after
7days’ injection, respectively, when compared with sham-control
group. We also examined RANTES protein expression in
hyperuricemia mice kidneys by western blot. Figure 2b shows
that RANTES protein expression was markedly increased after
induction of hyperuricemia, which were consistent with the
mRNA results.
We further investigated the expression of TNF-a, an inflam-
matory cytokine probably produced by infiltrated cells in
hyperuricemia mice kidneys. As presented in figure 2a, measured
by Q-PCR assay, TNF-a expression was also markedly increased
at both 7d and 14d.
Uric acid induces inflammatory cytokines and
chemokines expression in tubular cells
Since the infiltrated cells accumulated in tubular interstitial
spaces, we next examined the effects of uric acid on renal tubular
epithelial cells in vitro. NRK-52E cells were incubated with uric
acid at a concentration of 200mM for various times as indicated.
The expression of RANTES, MCP-1 and TNF-a were examined.
As shown in figure 3a through 3c, uric acid markedly induced
RANTES, MCP-1 and TNF-a mRNA expression. Further,
RANTES protein expression was also increased in NRK-52E
cells (figure 3d).
Blockage of urate transporters inhibits the induction of
RANTES, MCP-1 and TNF-a
Probenecid is a non-specific inhibitor of urate transporters on
the membrane of tubular epithelial cells, which has been widely
administered in hyperuricemia patients. We therefore reduced the
accumulation of uric acid in tubular cells by blocking its
transporters and then examined whether the induction of
RANTES, MCP-1 and TNF-a was inhibited. As shown in
figure 4, Q-PCR analysis demonstrated that probenecid (20mM)
inhibited RANTES, MCP-1 and TNF-a mRNA expression
induced by 12h of uric acid treatment. RANTES protein
expression induced by 24h of uric acid treatment was also
abolished. Hence, it suggested that urate transporters blockage
reduced the accumulation of uric acid in tubular cells, and
therefore abolished the induction of RANTES, MCP-1 and TNF-
a.
Modulation of urate transporter expression regulates
tubular express of RANTES, MCP-1 and TNF-a in response
to uric acid treatment
To further confirm the role of uric acid on induction of
RANTES, MCP-1 and TNF-a, a pair of reverse strategies was
applied. URAT1, one of the human urate transporters located on
the apical membrane of tubular epithelial cells, was identified to
play important roles in homeostasis, which might sensitize uric
acid-induced tubular injury. As shown in figure 5a, expression of
URAT1 was up-regulated after 24h of plasmid transfection. After
that, cells were incubated with 200mM of uric acid for another 6h.
As compared with cells transfected with empty vector (pcDNA3),
URAT1 plasmid transfection markedly sensitized tubular express
of RANTES, MCP-1 and TNF-a mRNA (figure 5c). After 24h of
uric acid treatment, RANTES protein expression was also
significantly increased in URAT1-transfected cells (figure 5d).
On the contrary, expression of URAT1 was down-regulated after
24h of siRNA transfection (figure 5f). As one of the members of
urate transporters on tubular cells, down-regulation of URAT1
(figure 5g) partially decreased tubular express of RANTES, MCP-
1 and TNF-a mRNA after 6h of uric acid incubation (figure 5h).
These results confirmed the effect of accumulated uric acid on
induction of RANTES, MCP-1 and TNF-a. In addition, urate
transporters mediated uptaking of uric acid into tubular cells were
indispensable in the pathologic conditions.
Uric acid induces the recruitment of macrophage in vitro
We further examined the chemo-attractive abilities of tubular
cells after uric acid incubation by chemotaxis assay. NRK-52E
cells were treated with uric acid (200mM) for 24h. The culture
media were collected and their abilities to attract macrophage
recruitment were assess. Figure 6b and 6c showed that media of
uric acid incubated NRK-52E cells were more potent to attract
macrophage, compared with control. The chemo-attractive effects
of the media were abolished with the presence of probenecid
(20mM), which suggested that although uric acid may directly
mediate the recruitment of macrophage, uric acid activated
cytokines are more potent and critical for attracting macrophage
migration.
Uric acid activates NF-kB signaling pathway in tubular
cell
Since NF-kB signaling is important in inflammation, we
speculated that RANTES expression may be regulated by NF-
kB signaling. We examined the expression of activated p65 NF-kB
protein in NRK-52E cells incubated with uric acid for various time
periods. As shown in figure 7a, phosphorylation of p65 NF-kB was
observed as early as 5min after uric acid incubation. However, the
total p65 NF-kB abundance was not altered at different time
points. Similar results were obtained for phosphor-IkB-a
(figure 7b). The nuclear translocation of p65 NF-kB after uric
acid treatment was then examined. Immunofluorescent staining
demonstrated that upon uric acid stimulation, p65 NF-kB rapidly
translocated into the nuclei of NRK-52E cells (figure 7e).
NF-kB signaling is critical for RANTES induction in tubular
cell
To test the importance of NF-kB signaling in RANTES
induction in tubular cells, we treated NRK-52E cells with uric
acid in the absence or presence of specific NF-kB inhibitor (NF-kB
SN50), a cell permeable inhibitor peptide which inhibit p65
translocation (figure 8a). As shown in figure 8b, inhibition of NF-
kB signaling abolished RANTES expression induced by uric acid,
suggesting that NF-kB signaling is required for RANTES
induction.
Uric acid activates NF-kB signaling in vivo
We next investigated whether NF-kB signaling was activated in
hyperuricemia mice kidney. As shown in figure 9, continuous
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western blot analysis of whole-kidney lysates. Immunofluorescence
staining demonstrated that p65 NF-kB was localized in the
cytoplasm of tubular cells in sham-control kidney; however, uric
acid induced p65 NF-kB nuclear translocation apparently, which
is similar to uric acid treatment in vitro.
Figure 1. Uric acid induces renal infiltration of T cells and macrophages. (a) Representative micrographs show kidney morphology by H/E
staining. (b) Immunohistochemical staining revealed an increased infiltration of CD3+ T cells in kidney of hyperuricemia mice after continuous
injection of 7d and 14d, respectively. (c) Immunohistochemical staining revealed an increased infiltration of CD68+ macrophage in kidney of
hyperuricemia mice after continuous injection of uric acid for 7d and 14d, respectively. (d) Mice were daily injected with uric acid intraperitoneally. At
different time points, as indicated, serum was collected and serum urate levels (mmol/L) were determined. Data are presented as mean 6 SEM from
five animals per group at each time point, *P,0.05 versus sham (e and f) Graphic presentations of quantitative data. Positive cell numbers per high-
power field (6400) were counted. Ten randomly selected field of each kidney were counted. Data are mean 6 SEM of five animals per group. *P,0.05
versus sham-control.
doi:10.1371/journal.pone.0039738.g001
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In this study, hyperuricemia mice model were induced by
intraperitoneally injection of uric acid (figure 1d) as previously
described [15,17,18]. Results demonstrate that uric acid induces
renal inflammation by recruiting T cells and macrophage
infiltration and pro-inflammatory cytokines and chemokines
expression in hyperuricemia mice kidneys. NF-kB signaling, a
principal signaling pathway mediating pro-inflammatory response
in various conditions, was activated in tubule of hyperuricemia
mice. Because uric acid is a well-known pro-inflammatory factor
and inflammation is a critical mechanism contributing to the
progression of renal injury, our study shed new light on
understanding the pathogenesis of hyperuricemia renal injury.
Previous investigations showed that fructose, a metabolic source
of uric acid, could induce pro-inflammatory mediators in human
proximal tubular cells [19]. TNF-a is known to be an important
pro-inflammatory cytokine produced by infiltrated cells. It
stimulates tubular cells to produce chemokines which, in turn,
recruit inflammatory cells. TNF-a is also implicated to be induced
Figure 2. Uric acid induces RANTES, MCP-1 and TNF-a expression in hyperuricemia mice kidneys. (a) Q-PCR results showed that renal
RANTES, MCP-1 and TNF-a mRNA expression were increased in kidney of hyperuricemia mice after continuous injection of uric acid for 7d and 14d,
respectively. *P,0.05 versus sham-control. (b) Western blot results showed that renal RANTES protein expression was increased in hyperuricemia
mice kidneys. (c) Graphic presentation of relative RANTES protein abundance normalized to actin. *P,0.05 versus control (n=5).
doi:10.1371/journal.pone.0039738.g002
Figure 3. Uric acid induces RANTES, MCP-1 and TNF-a expression in tubular epithelial cells. (a through c) Q-PCR results showed that
RANTES, MCP-1 and TNF-a mRNA expression were increased in NRK-52E cells after uric acid treatment for different time periods as indicated. *P,0.05
versus control. (b) Western blot results showed that RANTES protein expression was increased in NRK-52E cells after uric acid treatment. (c) Graphic
presentation of relative RANTES protein abundance normalized to actin. *P,0.05 versus control (n=3).
doi:10.1371/journal.pone.0039738.g003
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has been characterized in a variety of kidney disorders, including
acute kidney injury and chronic renal fibrosis [21,22,23]. In this
study, the expression of TNF-a was increased as early as 1h and
reached the peak at 24h (figure 3c) in tubular cells, which might
create a vicious circuit leading to a sustained chemokines
production and inflammatory infiltration in the circumstance of
hyperuricemia. On the other hand, RANTES expression was
markedly increased and kept at a high level till 24h (figure 3a). The
diverse expression patterns might suggest different regulation
mechanisms of TNF-a and RANTES in hyperuricemia. The
extended effects of TNF-a induction on tubular cells and possible
influence on RANTES and MCP-1 expression need further
investigations.
In the human kidneys, 90% of filtered urate is reabsorbed via
transporters located in the apical membrane of the proximal
tubules. Previous investigations showed an up-regulation of
URAT1 expression induced by uric acid treatment in proximal
tubular cells [15]. The hyperuricosuria caused by hyperuricemia
and up-regulation of urate transporter, will probably increase the
quantity of uric acid in proximal tubular cells, which aggravates
uric acid-induced tubule dysfunction. In this study, up-regulation
of URAT1 by plasmid transfection sensitizes tubular express of
RANTES, MCP-1 and TNF-a in response to uric acid treatment
(figure 5). While blockage of urate transporter by non-specific
inhibitor, probenecid, markedly inhibits tubular induction of
RANTES, MCP-1 and TNF-a (figure 4). However, blockade of
URAT1 only partially abolished RANTES, MCP-1 and TNF-a
expression, which might be reasonable as URAT1 is only one of
numerous transporter proteins in epithelial cells. Blockage of
URAT1 could not abolish the uptake of uric acid mediated by
other transporters. These results further confirmed the effect of
accumulated uric acid on induction of RANTES, MCP-1 and
TNF-a, which also suggest that urate transporter mediated uric
acid accumulation in tubule plays important role in mediating
tubule inflammation.
Chemokines and cytokines play fundamental roles in recruit-
ment and activation of effecter inflammatory cells. As inflamma-
tory cells are no longer the only cells contribute to development of
inflammation, tubular epithelial cells, the largest cell population in
kidney parenchyma, are important players in renal inflammation
after injury. Tubular production of RANTES and MCP-1
inevitably contributes to the formation of a chemo-attractive
microenvironment, which attract the infiltration of T cells and
macrophages into tubular interstitial spaces [20,24]. In this study,
as shown by chemotaxis assay, although uric acid may directly has
chemo-attractive effect on macrophages, tubular expression and
secretion of RANTES and MCP-1 stimulated by uric acid are
more potent and critical for attracting macrophage migration
(figure 6).
In this study, uric acid induces renal inflammation via NF-kB
signaling. Transcription factor NF-kB is silenced by its specific
inhibitor, IkB, in normal resting state. Upon activation, after
phosphorylation and degradation of IkB, NF-kB is released and
translocated in to nucleus to dictate the transcription of its target
genes. RANTES is one of the genes controlled by NF-kB. The
data presented in this study suggest that uric acid activates NF-kB
signaling in both hyperuricemia mice kidneys and tubular
epithelial cells. Moreover, RANTES expression stimulated by
uric acid is NF-kB dependent (figure 8). Although the protective
effect of NF-kB inhibition in vitro is clear, it remains to be
determined whether this therapeutic strategy is operative in vivo for
ameliorating renal inflammation. In addition, the possibility that
uric acid regulates inflammatory mediator expression by signaling
Figure 4. Blockage of urate transporter by probenecid inhibits uric acid-induced RANTES, MCP-1 and TNF-a expression in tubular
epithelial cells. (a through c) Q-PCR results showed that probenecid inhibits uric acid-induced RANTES (a), MCP-1 (b) and TNF-a (c) mRNA
expression in NRK-52E cells. *P,0.05 versus control. #P,0.05 versus uric acid treated cells without probenecid incubation (n=3). (d) Western blot
results showed that probenecid inhibits uric acid-induced RANTES protein expression in NRK-52E cells. (e) Graphic presentation of relative RANTES
protein abundance normalized to actin. *P,0.05 versus control. #P,0.05 versus uric acid treated cells without probenecid incubation (n=3).
doi:10.1371/journal.pone.0039738.g004
Uric Acid Induces Renal Inflammation via NF-kB
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39738mechanisms other than NF-kB could not be excluded, as blockage
of p65 NF-kB translocation only partially abolish TNF-a and
MCP-1 induction (data not shown), which suggested that TNF-a
and MCP-1 were not totally regulated by NF-kB. Meanwhile,
recent studies suggested that uric acid crystals engaged NALP3
inflammasome to induce tubular-interstitial inflammation [10,25].
Furthermore, NF-kB is an important transcription factor that
regulates genes involved in immune development [26], synaptic
plasticity and memory [27]. Glucocorticosteroid has already been
administered for gout patients; however, there remains a long
distance towards the administration of NF-kB inhibitor in clinical
settings.
In summary, we showed in this study that uric acid induced
infiltration of inflammatory cells and production of inflammatory
mediators in hyperuricemia mice. These pro-inflammatory effects
may be mediated by activation of NF-kB signaling. Therefore, in
addition to cause arthritis in gout, uric acid also causes
inflammation via NF-kB signaling in kidney, which might provide
a therapeutic target in clinical settings.
Figure 5. Modulation of urate transporter regulates tubular express of RANTES, MCP-1 and TNF-a in response to uric acid
treatment. (a) RT-PCR analysis showed the URAT1 expression level after plasmid transfection for 24h. (b) Graphic presentation of relative mRNA
abundance normalized to actin. *P,0.05 versus pcDNA3 transfected group (n=3). (c) Q-PCR results showed that upregulation of URAT1 by plasmid
transfection sensitized tubular express of RANTES, MCP-1 and TNF-a mRNA after 6 h of uric acid treatment. *P,0.05 versus control. #P,0.05 versus
cells transfected with pcDNA3 (n=3). (d) Western blot results showed that upregulation of URAT1 by plasmid transfection sensitized tubular express
of RANTES protein after 24h of uric acid treatment. (e) Graphic presentation of relative RANTES protein abundance normalized to actin. *P,0.05
versus control. #P,0.05 versus uric acid treated cells transfected with pcDNA3 (n=3). (f) RT-PCR analysis showed the URAT1 expression level after
transfection of URAT1 siRNA for 24h. (g) Graphic presentation of relative mRNA abundance normalized to actin. *P,0.05 versus negative control
(N.C.) siRNA transfected group (n=3). (h) Q-PCR results showed that downregulation of URAT1 by RNA interference partially decreased tubular
express of RANTES, MCP-1 and TNF-a mRNA after 6h of uric acid treatment in NRK-52E cells. *P,0.05 versus control. #P,0.05 versus uric acid treated
cells transfected with negative control siRNA (n=3).
doi:10.1371/journal.pone.0039738.g005
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Ethics statement
All of the following details of the study were approval by
institutional review board of Nanjing Medical University.
Animals
Male CD-1 mice weighing 18–22 g were acquired from
Shanghai Experimental Animal Center of Chinese Academy of
Science. They were housed in the animal facilities of Center for
Kidney Disease of Nanjing Medical University with free access to
food and water and treated in compliance with the regulations and
protocols of institutional review board of Nanjing Medical
University. Mouse hyperuricemia model was generated by daily
Figure 6. Culture media from uric acid treated tubular cells induce the recruitment of macrophage in vitro. Probenecid reduces the
media-induced recruitment of macrophage. (a) Schematic depiction of the chemotaxis assay. Macrophage monolayer on transwell filters was
incubated conditioned media from NRK-52E cells treated with or without uric acid for 4 hours, and macrophage migration was then determined. (b)
Representative pictures show the migrated macrophage in the bottom chambers of transwell plates in various groups as indicated. (c) For
quantification, positive stained nuclei per field (6200) were counted. Ten randomly selected fields were counted. As for the total cell number, ten
randomly chose fields (6200) were counted before the chemotaxis assay. Data are expressed as the percentage of migrated cells in total cells added
and presented as means 6 SEM of three independent experiments. *P,0.05 versus control.
doi:10.1371/journal.pone.0039738.g006
Figure 7. Uric acid activates NF-kB signaling in tubular epithelial cells. (a) Western blot analysis showed that uric acid induced p65 NF-kB
phosphorylation and activation in NRK-52E cells. (b) Western blot showed that uric acid induced IkB phosphorylation in NRK-52E cells. (c) Graphic
presentation of relative phosphs-p65 NF-kB protein abundance normalized to p65 NF-kB. *P,0.05 versus control (n=3). (d) Graphic presentation of
relative phosphs-IkB protein abundance normalized to IkB. *P,0.05 versus control (n=3). (e) Immunofluorescence staining demonstrated that p65
NF-kB underwent nuclear translocation upon uric acid stimulation in NRK-52E cells.
doi:10.1371/journal.pone.0039738.g007
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[15,17,18] For the sham-control group, normal saline was
administered. Groups of mice (n=5) were killed at 7 and 14 d,
respectively, and the kidneys were removed for various analyses.
Cell culture and treatment
Normal Rat Kidney epithelial cells (NRK-52E) were obtained
from cell resource center of Shanghai Institutes for Biological
Sciences Chinese Academy of Sciences, which was originally came
from ATCC (CRL-1571TM). Cell culture and uric acid
treatments were carried out according to the procedures described
previously [15]. Briefly, NRK-52E cells (1.0610
6) were seeded in
DMEM-F12 medium that contained 10% FBS at approximately
80% confluence. After an overnight incubation, cells were serum-
starved in serum-free medium for 24 h before addition of sterile
uric acid. The concentration of uric acid applied in this study was
200mM. For blocking the kidney urate transporter, NRK-52E cells
were incubated with probenecid (P8761, Sigma-Aldrich) at a
concentration of 20 mM. For blocking NF-kB signaling, NRK-52E
cells were pretreated with NF-kB SN50 (Calbiochem), a cell-
permeable inhibitor peptide, at a concentration of 20 mM for 1 h
and then incubated with uric acid. Whole-cell lysates or
conditioned media were prepared and then subjected to various
analyses.
Plasmids transfection
URAT1 expression plasmid was kindly provided by 301
Hospital of PLA, Beijing, China. The empty expression plasmid
vector pcDNA3 was purchased from Invitrogen (San Diego, CA,
USA). Plasmids DNA (4mg in 2ml medium) were transiently
transfected into cells using Liptofectamine 2000 transfection
reagent (Invitrogen) according to the protocols provided by the
manufacturer. Twenty-four hours after transfection, cells were
used for experiments.
URAT1 knockdown by siRNA transfection
SiRNA and negative control siRNA (acquired from Ambion)
(100 pmol/2ml medium without antibiotics) were transfected into
cells using Lipofectamine 2000 reagent (Invitrogen) according to
the protocols provided by the manufacturer and then incubated at
37uC in a CO2 incubator for 24h until the cells were ready for
assay.
Western blot analysis
The preparation of whole-cell lysates and kidney tissue
homogenates and western blot analysis of protein expression were
carried out using previous routine procedures [28]. The primary
antibodies used were as follows: Anti-RANTES (sc-1410; Santa
Cruz Biotechnology); anti-phospho p65 NF-kB (Ser536) (93H1)
(3033; Cell Signaling Technology), anti-p65 NF-kB (3034; Cell
Signaling Technology), anti-phospho IkB-a (Ser32) (14D4) (2859;
Cell Signaling Technology), anti-IkB-a (44D4) (4812; Cell
Signaling Technology) and anti-actin (A5385; Sigma Aldrich).
Quantification was performed by measurement of the intensity of
the signals with aid of National Institutes of Health Image software
package.
Quantitative polymerase chain reaction
Quantitative polymerase chain reaction (Q-PCR) was per-
formed using an Applied Biosystems 7300 Sequence Detection
system. The CT data were determined using default threshold
settings and the mean CT was determined from the duplicate
PCRs. The ratio to sham-control group was calculated by using
the equation 2
-DCT, in which DCT = CT Sample-CT control. All the
primers were acquired from QIAGEN.
Reverse transcriptase-polymerase chain reaction analysis
Total RNA was prepared using a TRIzol RNA isolation system
according to the instructions by the manufacturer (Invitrogen).
The first strand of cDNA was synthesized using 2 mg of RNA in
20 ml of reaction buffer using MLV-RT (Promega, Madison, WI)
and random primers at 42uC for 30 minutes. PCR was performed
using a standard PCR kit on 1ml aliquots of cDNA and
HotStarTaq polymerase (Promega, Madison, WI) with specific
primer pairs. The sequences of primer pairs were as follows:
URAT1(forward) 59- GTC TTC ACT GGG CAG CTT CTG-39
and (reverse) 59- CAA ACA GGT ATG GCC AGG TAC TC-39;
b-Actin (forward) 59-CAG CTG AGA GGG AAA TCG TG-39
and (reverse) 59-CGT TGC CAA TAG TGA TGA CC-39. The
PCR products were size fractionated on a 1% agarose gel and
detected by NA-green (D0133, Beyotime) staining. Quantification
was performed by measurement of the intensity of the signals with
aid of National Institutes of Health Image software package.
Immunohistochemical and Immunofluorescence Staining
Immunohistochemical staining of kidney sections was per-
formed according to an established protocol [28]. In brief,
paraffin-embedded sections were stained with anti-CD3 (sc-
20047; Santa Cruz Biotechnology) and anti-CD68 (ab995;
Abcam) antibodies using the Vector M.O.M. immunodetection
kit, according to the protocol by the manufacturer (Vector
Figure 8. NF-kB signaling is critical for mediating RANTES
expression in tubular cells. NRK-52E cells were treated with
200mmol/L of uric acid in the absence or presence of NF-kB inhibitor
(NF-kB SN50). (A) Immunofluorescence staining demonstrated that
incubation with NF-kB SN50 inhibited nuclear translocation of p65 NF-
kB upon uric acid stimulation in NRK-52E cells. (b) Inhibition of NF-kB
signaling abrogated RANTES expression stimulated by uric acid in NRK-
52E cells.
doi:10.1371/journal.pone.0039738.g008
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staining was carried out according to the procedures described
previously [28]. Briefly, cells or kidney cryosections were
incubated with the specific primary anti-p65 NF-kB antibody
(3034; Cell Signaling Technology), followed by staining with
cyanine Cy3–conjugated secondary antibody (Jackson ImmunoR-
esearch Laboratories). Cells were double stained with DAPI to
visualize the nuclei. Slides were viewed with a Nikon Eclipse E80i
microscope equipped with a digital camera (DS-Ri1, Nikon). CD3
and CD68 positive cell numbers per high-power field (6400) were
counted. Ten randomly selected field of each kidney were counted.
Morphological Studies
Tissue sections from the mice were prepared at 3mm thickness
by a routine procedure. Sections were stained with hematoxylin/
eosin for general histology. Slides were viewed with a Nikon
Eclipse E80i microscope equipped with a digital camera (DS-Ri1,
Nikon).
Chemotaxis assay
Cell chemotaxis assay was performed using 24-well transwell
plant following the procedure as described previously [20].
Macrophages (5610
5 in 100ml) were freshly prepared from mouse
peritoneal fluid and added onto the upper chamber of the
transwell insert (5mm; Corning). NRK-52E conditioned media
(0.5ml) were added in the lower chamber. After incubation at
37uC for 4h, cells were stained with DAPI and viewed with
microscope and counted. Data are expressed as percentage of the
migrated cells in total number of input cells. For quantification,
positive stained nuclei per field (6200) were counted. Ten
randomly selected fields were counted. As for the total cell
number, ten randomly chose fields (6200) were counted before the
chemotaxis assay.
Statistical analysis
Statistical analysis was performed using SigmaStat software
(Jandel Scientific Software). Comparisons between groups were
made using one-way ANOVA, followed by the t test. P,0.05 was
considered significant.
Figure 9. Uric acid activates NF-kB signaling pathway in kidney of hyperuricemia mice. (a) Western blot demonstrated that uric acid
induced p65 NF-kB phosphorylation and activation in kidney of hyperuricemia mice. (b) Western blot showed that uric acid induced IkB
phosphorylation in vivo. (c) Graphic presentation of relative phospho-p65 NF-kB and phospho-IkB protein abundance normalized to p65 NF-kB and
IkB, respectively. *P,0.05 versus control (n=3). (d) Immunofluorescent staining demonstrated that p65 NF-kB underwent nuclear translocation in
kidney of hyperuricemia mice. Kidney sections were immunostained for total p65 (red) and the nuclei (blue). Arrowheads indicate nuclear staining of
p65 NF-kB. (e) Enlarged image shows nuclear translocation of p65 NF-kB in tubules of hyperuricemia mice (day 7) demonstrated by
immunofluorescent staining.
doi:10.1371/journal.pone.0039738.g009
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